Home › Compare › VFRM vs BTI

VFRM vs BTI: Dividend Comparison 2026

VFRM yields 2000000.00% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VFRM wins by $1.6247481716182984e+23M in total portfolio value
10 years
VFRM
VFRM
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.6247481716182984e+23M
Annual income
$147,608,011,402,949,780,000,000,000,000.00
Full VFRM calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — VFRM vs BTI

📍 VFRM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVFRMBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VFRM + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
VFRM pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VFRM
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$125,466,809,692,507,310,000,000,000,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, VFRM beats the other by $125,466,809,692,507,310,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VFRM + BTI for your $10,000?

VFRM: 50%BTI: 50%
100% BTI50/50100% VFRM
Portfolio after 10yr
$8.123740858091492e+22M
Annual income
$73,804,005,701,474,890,000,000,000,000.00/yr
Blended yield
90.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

VFRM
No analyst data
Altman Z
-9.3
Piotroski
3/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VFRM buys
0
BTI buys
0
No recent congressional trades found for VFRM or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVFRMBTI
Forward yield2000000.00% ✓5.38%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%11.3% ✓
Portfolio after 10y$1.6247481716182984e+23M$37.7K ✓
Annual income after 10y$147,608,011,402,949,780,000,000,000,000.00 ✓$2,786.64
Total dividends collected$1.6146053563276882e+23M$14.3K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: VFRM vs BTI ($10,000, DRIP)

YearVFRM PortfolioVFRM Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$100,010,700$100,000,000.00$11,299$598.92+$100.00M → VFRM
2$467,446,731,075$467,339,719,626.17$12,794$703.91+$467446.72M → VFRM
3$1,021,215,363,816,662$1,020,715,195,814,411.90$14,518$829.07+$1021215363.80M → VFRM
4$1,043,112,617,104,109,200$1,042,019,916,664,825,300.00$16,513$978.64+$1043112617104.09M → VFRM
5$498,482,143,759,731,400,000$497,366,013,259,430,040,000.00$18,827$1,157.84+$498482143759731.38M → VFRM
6$111,599,275,650,097,780,000,000$111,065,899,756,274,860,000,000.00$21,518$1,373.12+$111599275650097776.00M → VFRM
7$11,738,678,336,351,557,000,000,000$11,619,267,111,405,953,000,000,000.00$24,657$1,632.46+$11738678336351557632.00M → VFRM
8$583,674,362,697,175,100,000,000,000$571,113,976,877,278,900,000,000,000.00$28,329$1,945.74+$583674362697175072768.00M → VFRM
9$13,894,210,989,607,547,000,000,000,000$13,269,679,421,521,570,000,000,000,000.00$32,637$2,325.33+$1.3894210989607547e+22M → VFRM
10$162,474,817,161,829,840,000,000,000,000$147,608,011,402,949,780,000,000,000,000.00$37,708$2,786.64+$1.6247481716182984e+23M → VFRM

VFRM vs BTI: Complete Analysis 2026

VFRM — Stock

Veritas Farms, Inc. focuses on producing, marketing, and distributing hemp oils and extracts containing phytocannabinoids. The company's products include capsules, gummies, tinctures, lotions, salves, vape oils, cream, balm sticks, lip balms, and pet chews. It markets and sells its products under the Veritas Farms brand name, as well as through white label and private label custom formulations for distributors and retailers. The company was formerly known as SanSal Wellness Holdings, Inc. and changed its name to Veritas Farms, Inc. in February 2019. Veritas Farms, Inc. is based in Dania Beach, Florida.

Full VFRM Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this VFRM vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VFRM vs SCHDVFRM vs JEPIVFRM vs OVFRM vs KOVFRM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.